Results 41 to 50 of about 1,180,314 (222)

Ebola Virüsü

open access: yesArşiv Kaynak Tarama Dergisi, 2015
Bu hastalık ismini1976'dailk kezgörüldüğü Kongo Demokratik Cumhuriyetindeki bir köye yakın olarak konumlanmış Ebola Nehrinden alır. Bu hastalığa Filoviridae ailesine mensup bir virüsten sebep olmaktadır. Ebola salgını başladığı günden bu yana temelde Batı Afrika'da yerleşim gösteren dört ülkeyi; Gine, Liberya, Sierra Leone ve Nijerya'yı ...
LAKSHMAN, Anusha   +2 more
openaire   +3 more sources

Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data

open access: yesThe Lancet Global Health, 2016
Background: Ebola virus has been detected in semen of Ebola virus disease survivors after recovery. Liberia's Men's Health Screening Program (MHSP) offers Ebola virus disease survivors semen testing for Ebola virus.
Moses J Soka, MD   +33 more
doaj   +1 more source

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures

open access: yesViruses, 2020
Filoviruses, such as Ebola virus and Marburg virus, are of significant human health concern. From 2013 to 2016, Ebola virus caused 11,323 fatalities in Western Africa.
Ryan P. Bennett   +10 more
doaj   +1 more source

Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Ebola virus disease (EVD) described as “one of the world’s most virulent diseases” by WHO was popularly known as Ebola haemorrhagic fever in the past. It is usually considered a severe and deadly illness when humans are concerned.
Deepak Passi   +4 more
doaj   +1 more source

On revealing the gene targets of Ebola virus microRNAs involved in the human skin microbiome [PDF]

open access: yesPeerJ, 2018
Ebola virus, a negative-sense single-stranded RNA virus, causes severe viral hemorrhagic fever and has a high mortality rate. Histopathological and immunopathological analyses of Ebola virus have revealed that histopathological changes in skin tissue are
Pei-Chun Hsu   +2 more
doaj   +2 more sources

Ferritin as a Nanoparticle Scaffold for Plant‐Produced Next‐Generation Subunit Vaccines

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Protein nanoparticles offer an innovative approach to next‐generation subunit vaccine development by displaying antigenic sequences on the nanoparticle surface. Compared to traditional subunit vaccines, protein nanoparticle vaccines often show improved interaction with the immune system due to their particulate size and repetitive epitope ...
Jordan T. VanderBurgt   +3 more
wiley   +1 more source

Ebola : too far or so close? [PDF]

open access: yes, 2014
The year 2014 has witnessed the escalation of the largest ever Ebola outbreak which started in Guinea, and later spread to other countries in West Africa.
Torpiano, Paul, Pace, David
core  

Mechanistic Digital Model for Real‐Time Monitoring and Optimization of Adenovirus Production

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Adenoviral vectors are a critical vaccine platform, with billions of vaccine doses administered during the COVID‐19 pandemic. In addition, they are promising therapeutics for cancer treatment. To advance their manufacturing, real‐time monitoring of adenovirus production is essential for process optimization, yield improvement, and product ...
Xingge Xu   +4 more
wiley   +1 more source

Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions

open access: yesJournal of Immunology Research, 2015
Ebola virus is responsible for causing severe hemorrhagic fevers, with case fatality rates of up to 90%. Currently, no antiviral or vaccine is licensed against Ebola virus. A phosphatidylserine-targeting antibody (PGN401, bavituximab) has previously been
S. D. Dowall   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy